A Patent Primer

The goal of patent laws is to promote inventiveness and public disclosure of useful knowledge. In return, inventors are granted exclusive use of their inventions for a specified period. To obtain a typical patent, U.S. law requires proof that an invention is: a new and useful process, machine, manufactured item, or chemical substance; novel (never before described or existing in nature in the described form); and nonobvious. Patents are not allowed on ideas per se, only the application of a

Written byLee Katterman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Patents are not allowed on ideas per se, only the application of an idea. Nor can discoveries of natural phenomena be patented. So a naturally occurring molecule cannot be patented, nor can a gene in a chromosome. But slightly alter the molecule, or isolate the DNA of the gene, and a patentable invention may now exist.

The patent process begins with an application that:

These last two items usually require close cooperation of the scientist-inventor(s) and attorneys expert in patent law.

The application is reviewed by a patent examiner, who searches the relevant scientific literature and past U.S. and foreign patent databases to make sure the proposed invention is new, useful, novel, and nonobvious. The patent examiner may raise objections, and the scientist-inventor can provide technical rebuttals to show why the objections are in error or modify the claims. This process, called the patent's "prosecution," can end in several months, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies